Skip to main content
OpenTrials

Clinical trial condition

Demyelinating Autoimmune Diseases, CNS

Explore clinical trials studying Demyelinating Autoimmune Diseases, CNS. Study availability and eligibility vary by location and protocol.

2,731 public trials 401 recruiting studies
Refine in advanced search Browse all conditions

Demyelinating Autoimmune Diseases, CNS trial results

Completed

This is an Extension Study of the Roche P-trials to Investigate Safety and Effectiveness of Ocrelizumab in Participants With Multiple Sclerosis (MS)

NCT03599245

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Hospital Churruca Visca Buenos Aires, Argentina
  • Centro de Especialidades Neurológicas y Rehabilitación - CENyR Ciudad Autonoma Buenos Aires, Argentina
  • Fundacion Rosarina de Neurorehabilitacion Rosario, Argentina
  • AZ Sint Jan Bruges, Belgium
View all 159 locations
View Trial Details
Completed

An Efficacy and Safety Study of Ravulizumab in Adult Participants With NMOSD

NCT04201262

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Central Nervous System Diseases, +26 more
Locations
  • Research Site Aurora, Colorado, United States
  • Research Site Fort Collins, Colorado, United States
  • Research Site Washington D.C., District of Columbia, United States
  • Research Site Miami, Florida, United States
View all 41 locations
View Trial Details

Related conditions